on 30 Jul 2024
Last Applicant/ Owned by
Ampersand Biomedicines, Inc.
55 Cambridge Parkway, Suite 800E, Cambridge MA 02142
US
Serial Number
2255711 filed on 7th Feb 2023
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceuticals and therapeutics. research and development services in the field of biotechnology and drug development.12
12
2255711
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 30th Jul 2024 | Search Recorded |
Submitted for opposition 256 on 4th Mar 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 135 on 22nd Feb 2024 | Amendment to Application |
Submitted for opposition 135 on 25th Jan 2024 | Amendment to Application |
Submitted for opposition 48 on 31st Oct 2023 | Agent Changed |
Submitted for opposition 257 on 4th May 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 3rd May 2023 | Created |
Submitted for opposition 31 on 3rd May 2023 | Formalized |
Submitted for opposition 30 on 7th Feb 2023 | Filed |
Submitted for opposition 228 on 7th Feb 2023 | International Registration |